quinoxalines has been researched along with Arterial Obstructive Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dina, JP; Feres, T; Paiva, AC; Paiva, TB | 1 |
| Cai, H; Fujishima, M; Ibayashi, S; Nakane, H; Uchimura, H; Yao, H | 1 |
| Ichiki, C; Kawasaki-Yatsugi, S; Minematsu, K; Shimizu-Sasamata, M; Takahashi, M; Toya, T; Yamaguchi, T; Yatsugi, S | 1 |
| Håberg, A; Haraldseth, O; Hjelstuen, M; Takahashi, M; Yamaguchi, T | 1 |
| Ichiki, C; Kawasaki-Yatsugi, S; Shimizu-Sasamata, M; Yamaguchi, T; Yatsugi, S | 1 |
| Ni, JW; Shimizu-Sasamata, M; Takahashi, M; Yamaguchi, T; Yatsugi, S | 1 |
| Haapalinna, A; Jolkkonen, J; Kauppinen, R; Koistinaho, J; Nieminen, L; Puurunen, K; Sivenius, J | 1 |
| Gerken, U; Hossmann, K; Vogel, P; Wiessner, C; Yamashita, K | 1 |
8 other study(ies) available for quinoxalines and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Role of membrane potential and expression of endothelial factors in restenosis after angioplasty in SHR.
Topics: Adrenergic alpha-Agonists; Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Brimonidine Tartrate; Carotid Arteries; Endothelin-1; Endothelium, Vascular; Hypertension; In Vitro Techniques; Male; Membrane Potentials; Nitric Oxide; Peptides; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Wistar | 2004 |
AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Infarction; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Hypertension; Intracranial Embolism and Thrombosis; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, AMPA | 1997 |
A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
Topics: Animals; Arterial Occlusive Diseases; Blood Gas Analysis; Body Temperature; Brain; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Infusions, Intravenous; Kidney; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Time Factors | 1998 |
Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Drug Evaluation, Preclinical; Imidazoles; Linear Models; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA | 1998 |
YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
Topics: Animals; Arterial Occlusive Diseases; Brain; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1998 |
Effects of YM872 on atrophy of substantia nigra reticulata after focal ischemia in rats.
Topics: Animals; Arterial Occlusive Diseases; Atrophy; Body Temperature; Body Weight; Brain Ischemia; Cerebral Infarction; Imidazoles; Male; Neurologic Examination; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Substantia Nigra | 1998 |
Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
Topics: Adrenergic alpha-Agonists; Animals; Arterial Occlusive Diseases; Body Weight; Cerebral Arteries; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Excitatory Amino Acid Antagonists; Imidazoles; Ischemic Attack, Transient; Male; Medetomidine; Neuroprotective Agents; Pipecolic Acids; Quinoxalines; Rats; Rats, Wistar | 1999 |
Biphasic expression of TGF-beta1 mRNA in the rat brain following permanent occlusion of the middle cerebral artery.
Topics: Animals; Arterial Occlusive Diseases; Brain; Cerebral Arteries; Chronic Disease; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Quinoxalines; Rats; Rats, Inbred F344; RNA, Messenger; Transforming Growth Factor beta | 1999 |